foxo4-dri senolytic peptide human trial Selectively Removes Senescent Cells From in vitro Expanded Chondrocytes ES2 rapidly destroys TP53-FOXO4 foci
ES2 rapidly destroys TP53 FOXO4 foci leading to TP53 mediated Download Scientific Diagram The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal FOX04 DRI (10mg) Nordsci Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv
Pay in 4 interest-free payments of $5.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16




